HPV Genotype Attribution and Disease Burden of Anal Cancer in China

Sponsor
Fudan University
Study ID
NCT06670495
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

To demonstrate HPV prevalence and its genotype distributions in anal cancer in China and to describe demographic and clinical features of HPV-related anal cancer in China; To describe the epidemiological characteristics ,trends and of disease burden of anal cancer in China

Key Dates

Start date
Jun 1, 2025
Status verified
Aug 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2028

Study Design

Enrollment
300 participants (estimated)

Primary Outcome Measure

Prevalence and types of distribution of HPV [ Time Frame: From enrollment to pre-treatment ]

Central Contacts

Related Studies